This compound is an Fmoc-protected amino acid derivative used as a building block in solid-phase peptide synthesis. It features a fluorenylmethoxycarbonyl (Fmoc) protecting group attached to the amino terminus of L-methionine, enabling controlled peptide chain assembly.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 71989-28-1
Fmoc-S-Methyl-L-Cysteine
research compound
Fmoc-L-Norvaline
pharmaceutical intermediate
N-Fmoc-S-trityl-L-homocysteine
pharmaceutical intermediate
Fmoc-L-propargylglycine
pharmaceutical intermediate
N-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-L-alanine--water (1/1)
pharmaceutical intermediate
N-Fmoc-L-Asparagine
pharmaceutical intermediate
3-[[(Acetylamino)methyl]thio]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valine
pharmaceutical intermediate
(2S)-1-(9H-fluoren-9-ylmethoxycarbonyl)pyrrolidine-2-carboxylic acid
pharmaceutical intermediate
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylsulfanylbutanoic acid
BUBGAUHBELNDEW-SFHVURJKSA-N
CSCC[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13